1. Home
  2. SKYW vs DVAX Comparison

SKYW vs DVAX Comparison

Compare SKYW & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWest Inc.

SKYW

SkyWest Inc.

HOLD

Current Price

$100.42

Market Cap

4.2B

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.38

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYW
DVAX
Founded
1972
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
1.3B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
SKYW
DVAX
Price
$100.42
$15.38
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
$124.75
$26.50
AVG Volume (30 Days)
276.5K
3.7M
Earning Date
01-29-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
78.86
N/A
EPS
10.47
N/A
Revenue
$3,978,113,000.00
$330,514,000.00
Revenue This Year
$16.39
$24.63
Revenue Next Year
$4.36
$15.85
P/E Ratio
$9.59
N/A
Revenue Growth
19.27
26.73
52 Week Low
$74.70
$9.20
52 Week High
$135.57
$15.49

Technical Indicators

Market Signals
Indicator
SKYW
DVAX
Relative Strength Index (RSI) 45.60 88.86
Support Level $99.97 $10.78
Resistance Level $103.02 $15.43
Average True Range (ATR) 2.34 0.17
MACD -0.56 0.51
Stochastic Oscillator 6.87 97.84

Price Performance

Historical Comparison
SKYW
DVAX

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers's brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines, which generates maximum revenue, and SkyWest Leasing.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: